Topical Compounded Pain Creams And Pain Perception (TOPCAPP)

Medimix Specialty Pharmacy, LLC

Status: Completed

Conditions: Pain

Study type: Observational

Funder types: Industry

Identifiers

NCT01862848

Medimix Pharm-01

Details and patient eligibility

About

To evaluate the change in patient pain perception with the use of a topical compounded pain cream regimen.

Full description

This is a prospective,observational,single center, open label study of patients that receive a combination topical compounded analgesic medication with no comparator group.

Enrollment: 285 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants must be diagnosed with an ICD9 code indicative of chronic pain.
• Participants must be starting a new regimen of topical therapy with multiple compounded agents.
• Participants must be expecting to receive therapy for at least 12 weeks.
• Participants must be between 18 and 65 years of age.
• Participants must be able to provide sound written and verbal informed consent.

Exclusion criteria

• Participants must not have prior hypersensitivity or adverse events to any of the components in the customized prescription.
• Participants must not be pregnant or breastfeeding women.
• Participants must not have a diagnosis of cancer within the past 5 years.